Skip to main content
Business Listing Info

Dreamly vs ArteraAI

A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.

Dreamly compared with ArteraAI
DetailDreamly logo DreamlyArteraAI logo ArteraAI
What it doesAI-assisted dream journal and interpretation app Personalized precision medicine powered by AI for cancer therapy
StageNot given Not given
Founded2023 Not given
Based inNot given US
Pricing modelFreemium Contact for pricing
PricingFree download with optional in-app subscriptions. New users receive three dream analyses free. Not given
Key features
  • AI-assisted personal interpretation
  • Recurring emotion and symbol tracking
  • Dream-inspired illustrations
  • Sleep sounds and ambient soundscapes
  • Lucid dreaming guides and breathing exercises
  • Dream dictionary
  • Pattern discovery and analytics
  • Private account with data controls
  • Account and dream deletion
  • Analyzes digital pathology with no additional tissue staining required
  • Rapid results within 1-2 days after specimen receipt
  • Validated across diverse populations including African American and non-African American men
  • FDA De Novo authorization for prostate cancer risk stratification
  • Insurance coverage for Medicare and many commercial plans
  • Provides 5 and 10-year distant metastasis risk for breast cancer
  • Identifies breast cancer patients who benefit from chemotherapy
  • Included in NCCN Clinical Practice Guidelines for Prostate Cancer
What makes it different
  • Personalized interpretation shaped by your specific emotions and life context, not generic symbolism
  • Combines journaling, interpretation, and pattern analysis in one app
  • Available in 11 languages worldwide
  • Integrated sleep tools with lucid dreaming practice support
  • No additional tissue preparation needed, uses existing H&E slides
  • Validated across multiple large randomized phase III clinical trials
  • FDA De Novo clearance as Software as a Medical Device
  • Financial assistance program to make tests affordable regardless of income
Community votes00
DR (Domain Rating by Ahrefs)27 −1 (down) since last check57 no change since last check
Trust Flow (Majestic)2315
Citation Flow (Majestic)2827
Referring domains (Majestic)300285

4 details filled in for both companies.

More alternatives to Dreamly More alternatives to ArteraAI

Questions?